Tenet Reports Strong Q2 Earnings with Revenue and Profit Growth
Tenet Healthcare Corporation (NYSE: THC) delivered strong financial performance for the second quarter of 2026, reporting net operating revenues of $5.628 billion—a 6.8% increase compared to the same period in 2025—driven by revenue growth at existing facilities and recent acquisitions. Adjusted EBITDA reached $1.304 billion with a margin of 23.2%, up from prior year levels, while adjusted diluted earnings per share (EPS) rose sharply by 52.2% to $6.12. The company also raised its full-year guidance for both net operating revenue and EBITDA due to better-than-expected performance across segments like ambulatory care and hospitals. Management highlighted disciplined cost control, strategic focus on high-acuity cases, and a robust M&A pipeline as key contributors to the results. Additionally, Tenet repurchased 5.7 million shares in Q2 for $1.04 billion and received an updated share buyback authorization of up to $2.13 billion.
Topics: ebitda eps healthcare revenue_growth